Diagnosis and management of hemorrhagic complications of percutaneous transhepatic biliary drainage: a primer for residents
Executive Summary
Percutaneous transhepatic biliary drainage (PTBD) is a critical interventional procedure for relieving biliary obstruction, particularly in patients with proximal tree obstructions or surgically altered anatomy. While technically effective, PTBD carries an overall complication rate of 12.9–67%, with hemorrhagic complications specifically occurring in 1.1% to 9.9% of cases. Given that the Society of Interventional Radiology (SIR) sets an acceptable major complication threshold of 10% and a hemorrhagic threshold of 5%, prompt recognition and management of bleeding are paramount.
Hemorrhage typically results from the close anatomical proximity of the biliary tree to the hepatic artery and portal vein within the portal tract. Risk factors include patient-specific comorbidities (chronic kidney disease, cirrhosis, advanced age) and procedural choices (large-bore needles, central duct punctures). Diagnosis relies on a combination of clinical presentation, cholangiography, and CT angiography. Management ranges from conservative measures like catheter repositioning or clamping for minor venous bleeds to active endovascular interventions, such as transarterial embolization (TAE) or stent-graft placement, for major arterial injuries and fistulas.
Anatomy and Pathophysiology of Hemorrhage
The biliary tree consists of extrahepatic and intrahepatic components. The intrahepatic portion—specifically second-order sectoral bile ducts—serves as the primary target for PTBD. These ducts reside within the portal tract, a connective tissue framework where branches of the hepatic artery and portal vein run in immediate proximity.
Because of this structural arrangement, vascular injury is a recognized risk during needle puncture or hardware manipulation. Bleeding may originate from:
Hepatic artery branches: Often presenting as high-pressure, significant hemorrhage.
Portal vein or hepatic vein tributaries: Generally lower-pressure, often self-limiting unless central branches are involved.
Liver parenchyma and tract vessels: Including the intercostal or internal mammary vessels lying along the percutaneous puncture path.
Risk Factor Stratification
Both patient-related and procedure-related factors significantly influence the likelihood of hemorrhagic complications.
To minimize risk, SIR guidelines recommend withholding antiplatelet and anticoagulant agents and ensuring INR is below 1.5 and platelet counts exceed 50,000/mm³ prior to the procedure.
Clinical Presentation and Diagnosis
Initial Presentation
Direct vascular injury often manifests as excessive bleeding through the tract during the procedure. While blood-stained bile is common for up to 48 hours post-procedure, the following signs necessitate investigation:
Persistent blood in drainage beyond 48 hours.
Pericatheter bleeding.
Hematemesis or melena.
Right upper quadrant or epigastric pain (indicative of subcapsular hematoma).
Unexplained hypotension or respiratory distress (suggesting hemoperitoneum or hemothorax).
Differentiating Arterial and Venous Injury
Venous Injury: Manifests as dark red blood or blood-tinged bile. It is rarely severe enough to cause a significant drop in hematocrit due to low intravascular pressure.
Arterial Injury: Characterized by bright red blood in the catheter, melena, and a precipitous fall in hematocrit (>13%).
Diagnostic Modalities
Cholangiography: The first choice for stable patients to assess catheter position and visualize vascular communication.
Pull-back Cholangiogram: Performed by injecting contrast while withdrawing a vascular sheath over a wire; useful for detecting occult venous bleeds.
Ultrasonography (USG): Used to identify hematomas (subcapsular or abdominal wall), hemoperitoneum, or pseudoaneurysms.
CT Angiography (CTA): The preferred initial study to identify pseudoaneurysms, active extravasation, or fistulas (arterioportal or arteriobiliary).
Digital Subtraction Angiography (DSA): The gold standard for identifying the exact site of arterial bleeding, particularly in hemodynamically unstable patients.
Management Strategies
Management is dictated by the hemodynamic status of the patient and the vascular source identified during diagnosis.
Venous Injury Management
Venous bleeds are often managed conservatively due to low pressure:
Minor Peripheral Bleeding: Managed by repositioning the catheter, clamping the catheter for 24–48 hours, or "upgrading" to a larger bore catheter to provide a tamponade effect.
Major Central Bleeding: May involve portobiliary fistulas. If conservative measures fail, management includes:
Tract Embolization: Using gel foam, glue, or coils.
Stent Graft Placement: Required for larger fistulas to exclude the communication while maintaining vessel patency.
Arterial Injury Management
Arterial injuries require active intervention to prevent life-threatening blood loss:
Transarterial Embolization (TAE): The treatment of choice with a success rate exceeding 95%.
Sandwich Technique: Placing coils both proximal and distal to a pseudoaneurysm or fistula to prevent retrograde filling.
Liquid Embolic Agents: n-butyl cyanoacrylate glue is used when a microcatheter cannot reach distal to the injury site.
USG-Guided Direct Percutaneous Thrombin/Glue Injection: An alternative for accessible pseudoaneurysms.
Empirical Embolization: If no source is visible on DSA, gel foam may be used to embolize the hepatic artery branch nearest the catheter.
Stent Grafts: Preferred in transplanted livers or cases of portal vein thrombosis to maintain hepatic arterial flow and avoid infarction.
Specialized Fistulas
Biliovenous Fistula: Often leads to "bilhemia" (disproportionately high bilirubin levels). These usually resolve spontaneously once the distal biliary obstruction is relieved.
Arteriobiliary/Arterioportal Fistulas: Generally present with significant hemobilia or shock; requires TAE or stent grafting.
Standardized Management Algorithm
The synthesized protocol for managing post-PTBD hemorrhage follows a structured decision-tree based on hemodynamic stability:
Initial Assessment: Evaluate vitals; provide fluid resuscitation/blood transfusion; check hematocrit, PT/INR, and platelet counts.
Stable Patients:
Conduct catheter cholangiogram, USG, or CTA.
If Venous: Attempt catheter repositioning, clamping, or upgrading. If bleeding persists, move to tract/portal vein embolization.
If Arterial: Proceed directly to DSA and TAE.
Unstable Patients:
Proceed directly to DSA.
Identify and treat arterial injury via TAE, USG-guided embolization, or stent grafts.
If no cause is identified, perform empirical segmental artery embolization using gel foam.
